Hot topics at ICH6
This article was originally published in SRA
Manuel Zahn looks at the agenda for the 6th International Conference on Harmonisation in Osaka in November, 2003
You may also be interested in...
New medicines under evaluation at the European Medicines Agency.
Formycon and partner Bioeq have offered further details on timing for the submission of their FYB201 proposed ranibizumab biosimilar version of Lucentis in Europe, the US and elsewhere.
The fresh cash injection will fund Phase II studies evaluating the UK firm's 12-month treatment for diabetic macular edema.